IFITM2 Human shRNA Plasmid Kit (Locus ID 10581)
CAT#: TG312241
IFITM2 - Human, 4 unique 29mer shRNA constructs in retroviral GFP vector, 5µg of each construct provided
Need custom shRNA service?
Get a free quote
CNY 4,790.00
货期*
现货
规格
Cited in 1 publication. |
Product images
经常一起买 (2)
IFITM2 mouse monoclonal antibody,clone OTI3B1
CNY 1,999.00
CNY 2,700.00
Specifications
Product Data | |
Product Name | IFITM2 Human shRNA Plasmid Kit (Locus ID 10581) |
Locus ID | 10581 |
UniProt ID | Q01629 |
Synonyms | 1-8D; DSPA2c |
Vector | pGFP-V-RS |
Format | Retroviral plasmids |
Kit Components | IFITM2 - Human, 4 unique 29mer shRNA constructs in retroviral GFP vector(Gene ID = 10581). 5µg purified plasmid DNA per construct29-mer scrambled shRNA cassette in pGFP-V-RS Vector, TR30013, included for free. |
RefSeq | NM_006435, NM_006435.1, NM_006435.2, BC009696, BC009696.1 |
Summary | IFN-induced antiviral protein which inhibits the entry of viruses to the host cell cytoplasm, permitting endocytosis, but preventing subsequent viral fusion and release of viral contents into the cytosol. Active against multiple viruses, including influenza A virus, SARS coronavirus (SARS-CoV), Marburg virus (MARV), Ebola virus (EBOV), Dengue virus (DNV), West Nile virus (WNV), human immunodeficiency virus type 1 (HIV-1) and vesicular stomatitis virus (VSV). Can inhibit: influenza virus hemagglutinin protein-mediated viral entry, MARV and EBOV GP1,2-mediated viral entry, SARS-CoV S protein-mediated viral entry and VSV G protein-mediated viral entry. Induces cell cycle arrest and mediates apoptosis by caspase activation and in p53-independent manner.[UniProtKB/Swiss-Prot Function] |
shRNA Design | These shRNA constructs were designed against multiple splice variants at this gene locus. To be certain that your variant of interest is targeted, please contact techsupport@origene.com. If you need a special design or shRNA sequence, please utilize our custom shRNA service. |
Performance Guaranteed | OriGene guarantees that the sequences in the shRNA expression cassettes are verified to correspond to the target gene with 100% identity. One of the four constructs at minimum are guaranteed to produce 70% or more gene expression knock-down provided a minimum transfection efficiency of 80% is achieved. Western Blot data is recommended over qPCR to evaluate the silencing effect of the shRNA constructs 72 hrs post transfection. To properly assess knockdown, the gene expression level from the included scramble control vector must be used in comparison with the target-specific shRNA transfected samples. For non-conforming shRNA, requests for replacement product must be made within ninety (90) days from the date of delivery of the shRNA kit. To arrange for a free replacement with newly designed constructs, please contact Technical Services at techsupport@origene.com. Please provide your data indicating the transfection efficiency and measurement of gene expression knockdown compared to the scrambled shRNA control (Western Blot data preferred). |
Citations (1)
The use of this RNAi has been cited in the following citations: |
---|
Respiratory Syncytial Virus Infection is Inhibited by Interferon-Induced Transmembrane Proteins
,Zhang, W;Zhang, L;Zan, Y;Du, N;Yang, Y;Tien, P;,
J. Gen. Virol.
,PubMed ID 25228491
[IFITM2]
|
Documents
Product Manuals |
FAQs |
SDS |
Customer
Reviews
Loading...